Top Markets
Coin of the day
Biocure Technology Inc. Biocure Technology Inc.

Biocure Technology Inc.

CURE
Rankning i aktier #39915
Biocure Technology Inc., operating with its subsidiary, focuses on the creation... Biocure Technology Inc., operating with its subsidiary, focuses on the creation and market introduction of biopharmaceutical innovations, particularly those involving recombinant technologies and ranibizumab. The company's current development pipeline includes: Interferons-ß, aimed at treating multiple sclerosis. Ranibizumab, a monoclonal antibody fragment designed to address macular degeneration and a related eye condition known as macular edema. Filgrastim, which targets neutropenia – a deficiency of white blood cells that can arise from cancer, bone marrow transplants, chemotherapy, or other medical issues. Additionally, Biocure is conducting research and development into several promising areas: CAR T-cell therapy, which works by identifying and eradicating cancer cells. A vaccine against foot and mouth disease. Various products for promoting hair growth. The firm was established in 2005 and its corporate headquarters are located in Vancouver, Canada.
Aktiekurs
$0.00366968
Senast synkroniserad: 2024-07-12
Marknadsvärde
$299.46K
Förändring (1 dag)
-66.77%
Förändring (1 år)
0.00%
Land
CA
Handel Biocure Technology Inc. (CURE)

Kategori

Vinst för Biocure Technology Inc. (CURE)
Vinst i 2026 TTM: 0
Enligt de senaste finansiella rapporterna från Biocure Technology Inc. är företagets nuvarande vinst 0. År 2026 hade företaget en vinst på 0, lika med vinsten år 2026 som var 0. Vinsten som visas på denna sida är vinsten före räntor och skatt, även kallad EBIT.
Vinshistorik för Biocure Technology Inc. från 2026 till 2026
Vinst vid slutet av varje år
År Vinst Ändra
Inte tillräckligt med data för de angivna datumen.
Vinst för liknande företag eller konkurrenter
Företag Vinst Skillnad i vinst Land
$5.27B -
US
$1.95B -
NL
- -
CH
- -
KR
$3.01B -
BE